About 2 results found for searched term "Zunsemetinib" (0.086 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25459 | Zunsemetinib | p38 MAPK |
| ATI-450; CDD-450 | ||
| Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. | ||
| M59015 | (R)-Zunsemetinib | MAPKAPK2/MAP3K/MAP4K |
| (R)-ATI-450; (R)-CDD-450 | ||
| (R)-Zunsemetinib is the isomer of Zunsemetinib, it can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
